Onco-Innovations Provides Information Regarding Exclusive License for Patented Drug with Potential to Enhance Cancer Treatment Options 
Aytu BioScience Announces Closing of $12.4M Prescription Product Portfolio Purchase
Asset Purchase Increases Combined Company Annual Revenue to $44M, Including Previously Announced Acquisition of Innovus Pharmaceuticals Over $5 Million in...
ENDRA Life Sciences to Host Key Opinion Leader (KOL) Event in Conjunction with the Annual 2019 AASLD Liver Meeting
Key Opinion Leader in hepatology and gastroenterology to discuss challenges and opportunities in NAFLD and NASH Company representatives to showcase...
Chemesis International Inc. Provides Update on Year-end Audited Financials
VANCOUVER, BC / ACCESSWIRE / November 4, 2019 / Chemesis International Inc. (CSE:CSI)(OTCQB:CADMF)(FRA:CWAA) (the "Company" or "Chemesis"), announces that it...
NanoViricides Completes Licensing for VZV Field which Includes Shingles Drug Development
SHELTON, CT / ACCESSWIRE / November 4, 2019 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), a global leader in nanomedicines...
Savonix and Boston University School of Public Health Launch Landmark Population Health Alzheimer’s Disease Discovery Study (ASSIST) to Digitally Collect Brain Health Data
- First-ever wholly digital population health study that captures data from multiple wearable technologies together with sensitive neuropsychology tests to...
Covetrus Partners with The Pet Fund® to Raise Money for Care of Diabetic Pets
Funds raised will provide diabetes medication for companion animals PORTLAND, Maine--(BUSINESS WIRE)--#Covetrus--In recognition of National Diabetes Month, Covetrus® (NASDAQ: CVET), a global leader...
Apollo Endosurgery, Inc. to Host Investor Meetings at Craig-Hallum Alpha Select Conference
AUSTIN, Texas--(BUSINESS WIRE)--Apollo Endosurgery, Inc. ("Apollo") (Nasdaq: APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric...
New Study Shows Vapotherm Hi-VNI® Technology Improved In-patient Participant Ambulation Recovery Time by 32.5% Versus Standard Oxygen Therapy
Study found that Hi-VNI Technology during ambulation is feasible Hi-VNI Technology improved recovery time amongst these patients by 32.5% versus...
EHNAC Releases New 2020 Accreditation Criteria Versions for Public Review through Dec. 31
Significant criteria updates include refocused privacy and security initiatives and new programs devoted to addressing alignment with the Trusted Exchange...
Additive Manufacturing in Orthopedics: Global Markets for 3D Printed Medical Implants 2019 – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Additive Manufacturing in Orthopedics: Markets for 3D Printed Medical Implants 2019" report has been added to ResearchAndMarkets.com's offering....
Axonics® Announces First Commercial U.S. Patient Implanted with its Sacral Neuromodulation System
IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable...
CynergisTek, Inc. Acquires Backbone Consultants to Bolster its Market Position as a Leader in Cybersecurity, Compliance, and Data Privacy
Acquisition Adds Security, IT Audit, and Data Privacy Capabilities to its Growing Managed Professional Service Offerings AUSTIN, Texas--(BUSINESS WIRE)--$CTEK #cybersecurity--CynergisTek,...
LiveData Names Patient Safety and Quality Executive Aileen Killen To New Position of Director of Operational Excellence
Nursing Executive Will Develop and Implement Strategies for Customer Adoption, Implementation of LiveData PeriOp Manager CAMBRIDGE, Mass.--(BUSINESS WIRE)--LiveData®, Inc., a...
LivaNova Honors Epilepsy Awareness Month
Company working to raise more awareness of epilepsy through partnerships LONDON--(BUSINESS WIRE)--$LIVN--LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation...
Motus GI to Release Third Quarter 2019 Results on Thursday, November 14, 2019
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company dedicated to...
Ares Management Corporation Highlights Third Quarter and Year-to-Date U.S. Direct Lending Commitments
Approximately $4.5 Billion in New U.S. Direct Lending Commitments Closed in the Third Quarter and Approximately $11.0 billion in the...
Theralase Announces Leadership Transition
TORONTO, ON / ACCESSWIRE / October 31, 2019 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage...
Trxade Group Generates Record Revenues in Third Quarter of 2019
Revenue Growth of 173% to $2.311 Million Operating Income Growth of 94% to $177,853 7th straight quarter of positive operating...
NanoViricides Initiates Required Dermal Sensitization and Ocular Irritation Testing of Lead Drug Candidate towards IND
SHELTON, CT / ACCESSWIRE / October 31, 2019 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a company with novel platform...
Prolung, Inc. Presents Highest Combined Sensitivity And Specificity Values For A Truly Non-Invasive Lung Cancer Solution Pursuing FDA Clearance At ISRD & ATS Joint Medical Conference
SALT LAKE CITY, UT / ACCESSWIRE / October 31, 2019 / ProLung, Inc. ("ProLung" or the "Company") and its long-time...